• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Surgeon Training Company Osso VR Closes $27M Series B

Share:

July 15, 2021

Osso VR, a San Francisco-based startup that developed a virtual reality tool to help surgeons plan for operations, landed $27 million in Series B funding.

GSR Ventures led the round with participation from Signalfire, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures, Leslie Ventures, and Anorak Ventures.

This comes less than a year after the company closed its $14 million Series A round led by Kaiser Permanente. After today’s announcement, the company’s total funding comes in at roughly $43 million.

WHAT IT DOES

The company has designed a number of virtual reality educational training tools to help surgeons plan for upcoming procedures.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The product also has an assessment tool and users are able to look at a digital dashboard and review their technical skills and proficiency data. Hospitals are able to work with the company to create custom content that applies specifically to their needs.

So far, the company boasts of operating in more than 20 countries and partnering with a number of hospital residency programs.

“The Osso platform’s level of immersion provides an experience that mirrors the operating room in a manner more efficient, more accessible, and more effective than any surgical training platform that’s come before,” Dr. Sunny Kumar, a partner at GSR Ventures, said in a statement.

WHAT IT’S FOR

The company said the new infusion of cash to expand its library and platform capabilities.

“Osso VR has been on an incredible journey. We have built a once-in-a-lifetime team, bringing together experts from healthcare, technology, movies, and gaming to pursue our mission: improve patient outcomes, accelerate the adoption of more effective surgical technologies and democratize access to education,” Dr. Justin Barad, CEO, and co-founder of Osso VR said in a statement.

“After proving the clinical effectiveness of the platform and its unique ability to scale up to the millions of providers around the world, we are ready to accelerate. With this latest round, we plan to exponentially expand our library and platform so that every patient in the world can have the peace of mind knowing they are getting access to the safest, highest-value procedures.”

MARKET SNAPSHOT

Osso VR isn’t the only virtual reality training tool on the market. London-based FundamentalVR also uses the technology to help train surgeons. Another U.K. startup, Touch Surgery, has also hit the market with its apps and augmented reality technology that helps doctor’s practice operations.

Virtual reality has also been used in the medical field to treat pain, distribute mental health treatment and provide remote physical therapy.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Mental Health App UpLift Health Closes $1M Seed FundingMental Health App UpLift Health Closes $1M Seed Funding
  • VBL Therapeutics and Notable Labs Announce Definitive Merger AgreementVBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
  • Could Artificial Intelligence Do More Harm Than Good in Healthcare?Could Artificial Intelligence Do More Harm Than Good in Healthcare?
  • Celling Spine Acquires Assets of Link Spine to Further Develop and Promote a Cell Centric Spine PlatformCelling Spine Acquires Assets of Link Spine to Further Develop and Promote a Cell Centric Spine Platform
  • BioArctic’s partner Eisai initiates BLA submission of data for lecanemab in ChinaBioArctic’s partner Eisai initiates BLA submission of data for lecanemab in China
  • India’s Bioeconomy Surge Towards $300 BillionIndia’s Bioeconomy Surge Towards $300 Billion
  • CORRECTING and REPLACING Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)CORRECTING and REPLACING Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)
  • Xcelerate, Inc. Signs Definitive Memorandum of Understanding with HS Pharmaceuticals, LLCXcelerate, Inc. Signs Definitive Memorandum of Understanding with HS Pharmaceuticals, LLC

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications